Exact Sciences Corporation
EXAS
$45.66
-$1.81-3.81%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.76% | -0.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.76% | -0.93% | |||
| Cost of Revenue | 20.56% | -27.41% | |||
| Gross Profit | 12.37% | 16.60% | |||
| SG&A Expenses | -5.44% | 7.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.55% | 4.38% | |||
| Operating Income | 103.39% | -95.03% | |||
| Income Before Tax | 99.94% | 88.47% | |||
| Income Tax Expenses | 403.57% | 101.97% | |||
| Earnings from Continuing Operations | 98.83% | 88.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 98.83% | 88.29% | |||
| EBIT | 103.39% | -95.03% | |||
| EBITDA | 311.76% | -341.02% | |||
| EPS Basic | 98.84% | 88.39% | |||
| Normalized Basic EPS | 105.57% | -107.16% | |||
| EPS Diluted | 98.84% | 88.41% | |||
| Normalized Diluted EPS | 105.57% | -107.16% | |||
| Average Basic Shares Outstanding | 1.12% | 0.81% | |||
| Average Diluted Shares Outstanding | 1.12% | 0.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||